U.S. researchers who reviewed nine studies of three cholinesterase inhibitors learned that the drugs, which treat cognitive problems in people with Alzheimer's disease, can also help control behavioral and psychological symptoms in such patients. Using this class of medicines could minimize the need for harmful drugs to manage dementia-related behavior, a study co-author said.

Full Story:

Related Summaries